{"id":2863,"date":"2026-08-21T20:47:03","date_gmt":"2026-08-21T19:47:03","guid":{"rendered":"https:\/\/seamlessbio.de\/?p=2863"},"modified":"2026-08-21T20:47:06","modified_gmt":"2026-08-21T19:47:06","slug":"fbs-bvdv-testing-cpe-rna-qpcr-guide","status":"publish","type":"post","link":"https:\/\/seamlessbio.de\/de\/fbs-bvdv-testing-cpe-rna-qpcr-guide\/","title":{"rendered":"FBS BVDV Testing \u2014 CPE vs RNA\/qPCR"},"content":{"rendered":"

<\/p>\n

August 2026 \u00b7 6 min read<\/em><\/p>\n

BVDV \u2014 bovine viral diarrhea virus \u2014 is the most significant viral contaminant risk in fetal bovine serum. It is also one of the most misunderstood aspects of FBS quality documentation. Many researchers assume that a “BVDV negative” result on the CoA means the serum is definitively free of BVDV. It may not.<\/p>\n

Here is what the standard test actually detects, where the limitations are, and when you need additional testing.<\/p>\n

Why BVDV matters in FBS<\/h2>\n

BVDV is a pestivirus endemic in cattle populations globally. Persistently infected (PI) animals \u2014 calves infected in utero during the first trimester before immune competence \u2014 shed high titres of BVDV throughout their lives without clinical signs. If a PI cow contributes to a serum collection batch, the resulting FBS can contain infectious BVDV at levels that infect cell cultures without visible cytopathic effect (CPE) \u2014 meaning contamination goes undetected by routine microscopy.<\/p>\n

BVDV contamination in cell culture causes: altered gene expression, interferon pathway activation, subtle growth changes that confound experimental data, and \u2014 critically \u2014 viral transmission to biopharmaceutical products manufactured in those cells. A 2025 Frontiers in Veterinary Science study identified infectious BVDV in commercial FBS that was confirmed by both indirect immunofluorescence and electron microscopy following six serial passages in MDBK cells.<\/cite> This illustrates that BVDV in commercial FBS remains an active real-world risk, not a theoretical one.<\/p>\n

Standard CoA BVDV testing \u2014 what it covers<\/h2>\n

The standard BVDV test on most FBS CoAs is the cytopathic effect (CPE) assay<\/strong> \u2014 also called the virus isolation assay. In this test:<\/p>\n

    \n
  1. FBS is inoculated onto MDBK (Madin-Darby bovine kidney) cells, which are susceptible to BVDV<\/li>\n
  2. Cultures are observed over 7\u201314 days for visible cytopathic effect<\/li>\n
  3. A positive result = visible cell destruction or morphology change<\/li>\n
  4. A negative result = no visible CPE detected<\/li>\n<\/ol>\n

    The limitation: the CPE assay only detects cytopathic BVDV strains<\/strong>. BVDV exists in two biotypes \u2014 cytopathic (cp) and non-cytopathic (ncp). The non-cytopathic biotype produces no CPE in cell culture despite active replication. PI cattle are persistently infected with ncp-BVDV \u2014 the most common source of FBS contamination \u2014 and ncp-BVDV will give a false negative CPE result<\/strong>.<\/p>\n

    Standard FBS CoA BVDV testing also includes antibody detection<\/strong> (ELISA or neutralisation assay) to detect anti-BVDV antibodies from immune animals in the donor pool. This is an indirect measure of viral exposure but does not directly detect viral RNA or infectious particles.<\/p>\n

    BVDV RNA\/qPCR testing \u2014 what it adds<\/h2>\n

    RT-qPCR (reverse transcription quantitative PCR) targeting conserved regions of the BVDV genome detects both cytopathic and non-cytopathic BVDV strains directly, without relying on cell culture. It is:<\/p>\n